nicht mehr verfügbar

DDX5020P-50 Roactemra (Tocilizumab) Antikörper

See related secondary antibodies

Search for all "Roactemra (Tocilizumab)"

Kurzübersicht

Mouse anti Human Roactemra (Tocilizumab) 107D8.04

Produktbeschreibung für Roactemra (Tocilizumab)

Mouse anti Human Roactemra (Tocilizumab) 107D8.04.
Presentation: Purified
Product is tested for ELISA (capture).

Produktdaten von Roactemra (Tocilizumab)

Produkt-Kategorie Primärantikörper
Menge 50 µg
Präsentation Purified
Reaktivität Hu
Anwendungen E(capture)
Klonalität Monoclonal
Klon 107D8.04
Wirt Mouse
Isotype IgG2a
Shipping to Germany, USA/Canada
PDF datasheet Datenblatt ansehen
Hersteller Dendritics SAS

Datenblatt-Auszug

Immunogen
Immunogen:
Roactemra ® (Roche) (Tocilizumab)
Isotype control AM03096PU-N
Anwendung Bridging ELISA positive control for anti-Roactemra detection, Capture antibody for Roactemra detection.
Background Roactemra® (Tocilizumab) is a humanized antibody targeting the interleukine - 6 receptor. This immunosuppressive drug is mainly used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis. We have generated a panel of anti - Roactemra (anti - Tocilizumab) murine monoclonal antibodies. These antibodies can be used to develop and calibrate Roactemra (Tocilizumab) and anti - Roactemra (anti - Tocilizumab) detection assays.
Concentration 0.5 mg/ml
Storage - 20°C. KEEP CONTENTS STERILE: no preservative. Avoid repeated freeze/thaw cycles.
Format
Purification:
QMA Hyper D ion exchange chromatography
Buffer System:
Tris - NaCl pH 8
State:
Purified
Specificity
Specificity:
Roactemra ® (Tocilizumab), negative for remicade (Infliximab) and mabthera (Rituximab)

Accessory Products

  • LinkedIn